Results
|
|
1.
|
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. MedStar authors:
- Dooley, Daniel J
- Lam, Phillip H
Year: 2018
Citation: - European Journal of Heart Failure. 20(2):359-369, 2018 02.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Aban IB, Adamopoulos C, Ahmed A, Allman RM, Anker SD, Aronow WS, Arundel C, Bhatt DL, Blackman MR, Butler J, Deedwania P, Dooley DJ, Filippatos GS, Fletcher RD, Fonarow GC, Forman DE, Kanonidis IE, Lam PH, Patel K, Pitt B, White M
|
|
|
2.
|
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial). MedStar authors:
Year: 2015
Citation: - American Journal of Cardiology. 115(6):790-6, 2015 Mar 15.
Institution: - MedStar Heart & Vascular Institute
All authors: - Butler J, Campia U, Chioncel O, EVEREST Trial Investigators, Gheorghiade M, Khan SS, Konstam MA, Maggioni AP, Nodari S, Rossignol P, Senni M, Subacius H, Swedberg K, Vaduganathan M, Zannad F
|
|
|
3.
|
Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving beta-blockers. MedStar authors:
- Bhyan, Poonam
- Dooley, Daniel J
- Lam, Phillip H
- Mohammed, Selma F
Year: 2018
Citation: - Clinical Cardiology. 41(3):406-412, 2018 Mar.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Ahmed A, Allman RM, Aronow WS, Arundel C, Bhyan P, Dooley DJ, Fonarow GC, Lam PH, Mohammed SF, Morgan CJ, Sheriff HM, Waagstein F
|
